Weber WA - Search Results

1

Imaging of esophageal and gastric cancer.

Weber WA, Ott K. Weber WA, et al. Semin Oncol. 2004 Aug;31(4):530-41. doi: 10.1053/j.seminoncol.2004.04.016. Semin Oncol. 2004. PMID: 15297944 Review.

2

Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.

Avril N, Dose J, Jänicke F, Ziegler S, Römer W, Weber W, Herz M, Nathrath W, Graeff H, Schwaiger M. Avril N, et al. J Natl Cancer Inst. 1996 Sep 4;88(17):1204-9. doi: 10.1093/jnci/88.17.1204. J Natl Cancer Inst. 1996. PMID: 8780629

3

Breast imaging with fluorine-18-FDG PET: quantitative image analysis.

Avril N, Bense S, Ziegler SI, Dose J, Weber W, Laubenbacher C, Römer W, Jänicke F, Schwaiger M. Avril N, et al. J Nucl Med. 1997 Aug;38(8):1186-91. J Nucl Med. 1997. PMID: 9255146 Free article.

4

Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.

Präuer HW, Weber WA, Römer W, Treumann T, Ziegler SI, Schwaiger M. Präuer HW, et al. Among authors: weber wa. Br J Surg. 1998 Nov;85(11):1506-11. doi: 10.1046/j.1365-2168.1998.00915.x. Br J Surg. 1998. PMID: 9823912 Clinical Trial.

5

Imaging of lung cancer with fluorine-18 fluorodeoxyglucose: comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system.

Weber WA, Neverve J, Sklarek J, Ziegler SI, Bartenstein P, King B, Treumann T, Enterrottacher A, Krapf M, Häussinger KE, Lichte H, Präuer HW, Thetter O, Schwaiger M. Weber WA, et al. Eur J Nucl Med. 1999 Apr;26(4):388-95. doi: 10.1007/s002590050402. Eur J Nucl Med. 1999. PMID: 10199945 Clinical Trial.

6

Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras.

Weber W, Young C, Abdel-Dayem HM, Sfakianakis G, Weir GJ, Swaney CM, Gates M, Stokkel MP, Parker A, Hines H, Khanvali B, Liebig JR, Leung AN, Sollitto R, Caputo G, Wagner HN Jr. Weber W, et al. J Nucl Med. 1999 Apr;40(4):574-8. J Nucl Med. 1999. PMID: 10210215 Free article. Clinical Trial.

7

Relevance of positron emission tomography (PET) in oncology.

Weber WA, Avril N, Schwaiger M. Weber WA, et al. Strahlenther Onkol. 1999 Aug;175(8):356-73. doi: 10.1007/s000660050022. Strahlenther Onkol. 1999. PMID: 10481766 Review.

8

Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.

Avril N, Rosé CA, Schelling M, Dose J, Kuhn W, Bense S, Weber W, Ziegler S, Graeff H, Schwaiger M. Avril N, et al. J Clin Oncol. 2000 Oct 15;18(20):3495-502. doi: 10.1200/JCO.2000.18.20.3495. J Clin Oncol. 2000. PMID: 11032590 Clinical Trial.

9

Quantitative assessment of tumor metabolism using FDG-PET imaging.

Weber WA, Schwaiger M, Avril N. Weber WA, et al. Nucl Med Biol. 2000 Oct;27(7):683-7. doi: 10.1016/s0969-8051(00)00141-4. Nucl Med Biol. 2000. PMID: 11091112 Review.

10

Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen.

Stahl A, Weber WA, Avril N, Schwaiger M. Stahl A, et al. Among authors: weber wa. Nuklearmedizin. 2000 Dec;39(8):241-5. Nuklearmedizin. 2000. PMID: 11189901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

397 results

Search Page